ArticlePloS one2021

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease.

Jeremy D Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.